Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Next Generation IV Infusion Pumps Market: By Product Type, By Application, By End-User and By Geography
Next-Generation IV Infusion Pumps Market size is expected to grow at a CAGR of 5.3% from 2024 to 2030. Next generation IV infusion pumps market growth driven by the innovation of newer pumps with modern technologies. Majority of the market players are developing newer technologies such as wearable insulin pumps, smartphone connected insulin pumps, and implantable insulin pumps among others, which are anticipated to fuel the market. Moreover, advantages with next generation pumps such as ease of using, patient safety, and accurate dosage also expected to bolster the market. Furthermore, acquisitions and mergers, product approvals, and product launchings are the strategies followed by market players for increasing their revenue share in next generation IV infusion pumps market. For instance, in May 2016, Hospira launched LifeCare PCA 7.0 next generation infusion system for patient controlled analgesia which enables auto-programming and streamline documentation of infusion data to improve the efficacy and safety of pain management medication administration. Next generation IV infusion pumps are the combination of intuitive user interface, simplicity, and state of art information technology. Next generation IV infusion pumps are inclined with the advanced pumping systems to improve the patient safety and work efficiency. A user interface is designed for next generation IV infusion pumps to diminish the programming errors to save the time and reduce in pump interactions. Next generation IV infusion pumps are frequently adopted by healthcare professionals to improve patient safety. The other advantages with next generation IV infusion pumps include affordability, flexibility, and ease of use, scalability, targeted delivering, and safer operability among others. in May 2016, Hospira launched LifeCare PCA 7.0 next generation infusion system for patient controlled analgesia which enables auto-programming and streamline documentation of infusion data to improve the efficacy and safety of pain management medication administration.
Study Period
2024-2030Base Year
2023CAGR
5.3%Largest Market
North AmericaFastest Growing Market
Europe
Increase in the prevalence and incidence of diabetes, malnutrition, neurological disorders, cancers, technological advancements in the devices, and ease of usage with more safety are anticipated to fuel the next generation IV infusion pumps market. Moreover, government support for start-ups, favorable regulatory policies, and expansion in production capacity are anticipated to boost the next generation IV infusion pumps market over the forecast period. However, product recalls, medicine dispensing errors, lack of skilled professionals, and lack of standard guidelines for product usage are anticipated to hinder the growth of next generation IV infusion pumps market over the forecast years.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market CAGR |
5.3% |
By Product Type |
|
By Application |
|
By End User |
|
Download Free Sample Report
The key segments covered in the Next Generation IV Infusion Pumps Market are: by product type, by application and by end users
The Next Generation IV Infusion Pumps Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
Europe is the fastest-growing for Next Generation IV Infusion Pumps Market
1.Executive Summary |
2.Global Next Generation IV Infusion Pumps Market Introduction |
2.1.Global Next Generation IV Infusion Pumps Market - Taxonomy |
2.2.Global Next Generation IV Infusion Pumps Market - Definitions |
2.2.1.Product Type |
2.2.2.Application |
2.2.3.End User |
2.2.4.Region |
3.Global Next Generation IV Infusion Pumps Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Next Generation IV Infusion Pumps Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Next Generation IV Infusion Pumps Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Syringe Infusion Pumps |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Large Volumetric Infusion Pumps |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Implantable Infusion Systems |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Patient Controlled Analgesia Pumps |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Disposable Elastomeric Infusion Systems |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Others |
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
6.Global Next Generation IV Infusion Pumps Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Analgesia |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Oncology |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Hematology |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Diabetes |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Neonatology |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Neurological Disorders |
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Gastroenterology |
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
6.8. Others |
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.8.3. Market Opportunity Analysis |
7.Global Next Generation IV Infusion Pumps Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Clinics |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Ambulatory Surgical Centers |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Next Generation IV Infusion Pumps Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Next Generation IV Infusion Pumps Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Syringe Infusion Pumps |
9.1.2.Large Volumetric Infusion Pumps |
9.1.3.Implantable Infusion Systems |
9.1.4.Patient Controlled Analgesia Pumps |
9.1.5.Disposable Elastomeric Infusion Systems |
9.1.6.Others |
9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Analgesia |
9.2.2.Oncology |
9.2.3.Hematology |
9.2.4.Diabetes |
9.2.5.Neonatology |
9.2.6.Neurological Disorders |
9.2.7.Gastroenterology |
9.2.8.Others |
9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Clinics |
9.3.3.Ambulatory Surgical Centers |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Next Generation IV Infusion Pumps Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Syringe Infusion Pumps |
10.1.2.Large Volumetric Infusion Pumps |
10.1.3.Implantable Infusion Systems |
10.1.4.Patient Controlled Analgesia Pumps |
10.1.5.Disposable Elastomeric Infusion Systems |
10.1.6.Others |
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Analgesia |
10.2.2.Oncology |
10.2.3.Hematology |
10.2.4.Diabetes |
10.2.5.Neonatology |
10.2.6.Neurological Disorders |
10.2.7.Gastroenterology |
10.2.8.Others |
10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Clinics |
10.3.3.Ambulatory Surgical Centers |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11.Asia Pacific (APAC) Next Generation IV Infusion Pumps Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Syringe Infusion Pumps |
11.1.2.Large Volumetric Infusion Pumps |
11.1.3.Implantable Infusion Systems |
11.1.4.Patient Controlled Analgesia Pumps |
11.1.5.Disposable Elastomeric Infusion Systems |
11.1.6.Others |
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Analgesia |
11.2.2.Oncology |
11.2.3.Hematology |
11.2.4.Diabetes |
11.2.5.Neonatology |
11.2.6.Neurological Disorders |
11.2.7.Gastroenterology |
11.2.8.Others |
11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Clinics |
11.3.3.Ambulatory Surgical Centers |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Next Generation IV Infusion Pumps Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Syringe Infusion Pumps |
12.1.2.Large Volumetric Infusion Pumps |
12.1.3.Implantable Infusion Systems |
12.1.4.Patient Controlled Analgesia Pumps |
12.1.5.Disposable Elastomeric Infusion Systems |
12.1.6.Others |
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Analgesia |
12.2.2.Oncology |
12.2.3.Hematology |
12.2.4.Diabetes |
12.2.5.Neonatology |
12.2.6.Neurological Disorders |
12.2.7.Gastroenterology |
12.2.8.Others |
12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Clinics |
12.3.3.Ambulatory Surgical Centers |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Next Generation IV Infusion Pumps Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Syringe Infusion Pumps |
13.1.2.Large Volumetric Infusion Pumps |
13.1.3.Implantable Infusion Systems |
13.1.4.Patient Controlled Analgesia Pumps |
13.1.5.Disposable Elastomeric Infusion Systems |
13.1.6.Others |
13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Analgesia |
13.2.2.Oncology |
13.2.3.Hematology |
13.2.4.Diabetes |
13.2.5.Neonatology |
13.2.6.Neurological Disorders |
13.2.7.Gastroenterology |
13.2.8.Others |
13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Clinics |
13.3.3.Ambulatory Surgical Centers |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Braun Melsungen AG (Germany) |
14.2.2.Johnson & Johnson Services, inc. (U.S.) |
14.2.3.Hoffmann-la Roche Ltd. (Switzerland) |
14.2.4.Baxter International, Inc. (U.S.) |
14.2.5.Zyno medical (U.S.) |
14.2.6.Smiths Medical (U.S.) |
14.2.7.Ivenix, Inc (U.S.) |
14.2.8.Hospira (Pfizer, Inc.) (U.S.) |
14.2.9.Becton, Dickinson, and Company (U.S.) |
14.2.10.Terumo Corporation (Japan) |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players